Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
LABORATORIO REIG JOFRE ( (ES:RJF) ) has shared an announcement.
Reig Jofre has announced the execution of a capital increase through a ‘scrip dividend’ or flexible dividend, allowing shareholders to receive either free shares or cash equivalent to a dividend payment. This move, approved by the Board of Directors, aims to provide shareholders with multiple options for their dividends, potentially impacting the company’s capital structure and shareholder value.
More about LABORATORIO REIG JOFRE
LABORATORIO REIG JOFRE is a company operating in the pharmaceutical industry, focusing on the development and production of pharmaceutical products. The company is involved in providing innovative healthcare solutions and is committed to enhancing the well-being of its stakeholders.
Average Trading Volume: 34,395
Technical Sentiment Signal: Buy
Current Market Cap: €240.2M
For an in-depth examination of RJF stock, go to TipRanks’ Stock Analysis page.